Bavarian Nordic A/S (OTCMKTS:BVNRY) Announces Quarterly Earnings Results

Bavarian Nordic A/S (OTCMKTS:BVNRY) released its quarterly earnings results on Friday. The company reported $0.13 earnings per share for the quarter, Zacks reports. Bavarian Nordic A/S had a return on equity of 10.65% and a net margin of 18.33%.

Bavarian Nordic A/S Stock Performance

Shares of OTCMKTS BVNRY opened at $7.82 on Friday. Bavarian Nordic A/S has a 52-week low of $6.60 and a 52-week high of $14.60. The firm has a 50 day moving average price of $7.64 and a two-hundred day moving average price of $8.54. The stock has a market cap of $1.85 billion, a P/E ratio of 11.33 and a beta of 1.44.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.